Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of vater

Steven Posner, Lisa Colletti, James Knol, Michael Mulholland, Frederic Eckhauser

Research output: Contribution to journalArticle

Abstract

Background. Ampullary tumors should be resected because of the high incidence of malignancy and the unreliability of preoperative endoscopic diagnosis. Controversy exists about whether to perform a transduodenal excision (TDE) or a pancreatoduodenectomy. This study evaluated the safety and long-term efficacy of TDE. Methods. The records of 21 patients with a pathologic diagnosis of ampullary adenoma who underwent TDE were reviewed. Demographics, symptoms, pathologic findings, and outcomes were analyzed and long-term follow-up was ascertained. Results. Twenty-one patients (mean age, 61 years) underwent TDE. Final pathology showed adenoma in all patients including 1 (5%) with invasive cancer, 2 (9%) with microinvasive cancer, 6 (28%) with high-grade dysplasia, and 1 (5%) with low-grade dysplasia. The overall survival was 85% (mean follow-up of 38 months). One of 3 late deaths was likely related to disease progression. Sixteen of the 18 remaining patients (89%) had no evidence of tumor recurrence. One benign ampullary recurrence was successfully treated endoscopically. One additional patient developed an ampullary cancer and underwent pancreatoduodenectomy. Conclusions. TDE of benign ampullary tumors, even those with varying grades of dysplasia, can be performed with acceptable morbidity and low rates of recurrence. Postoperative endoscopic surveillance is mandatory to identify recurrent tumors.

Original languageEnglish (US)
Pages (from-to)694-701
Number of pages8
JournalSurgery
Volume128
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Ampulla of Vater
Safety
Neoplasms
Pancreaticoduodenectomy
Recurrence
Adenoma
Disease Progression
Demography
Pathology
Morbidity
Survival
Incidence

ASJC Scopus subject areas

  • Surgery

Cite this

Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of vater. / Posner, Steven; Colletti, Lisa; Knol, James; Mulholland, Michael; Eckhauser, Frederic.

In: Surgery, Vol. 128, No. 4, 2000, p. 694-701.

Research output: Contribution to journalArticle

Posner, Steven ; Colletti, Lisa ; Knol, James ; Mulholland, Michael ; Eckhauser, Frederic. / Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of vater. In: Surgery. 2000 ; Vol. 128, No. 4. pp. 694-701.
@article{48c6b4479cad494e9406fe0e9ed7abd7,
title = "Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of vater",
abstract = "Background. Ampullary tumors should be resected because of the high incidence of malignancy and the unreliability of preoperative endoscopic diagnosis. Controversy exists about whether to perform a transduodenal excision (TDE) or a pancreatoduodenectomy. This study evaluated the safety and long-term efficacy of TDE. Methods. The records of 21 patients with a pathologic diagnosis of ampullary adenoma who underwent TDE were reviewed. Demographics, symptoms, pathologic findings, and outcomes were analyzed and long-term follow-up was ascertained. Results. Twenty-one patients (mean age, 61 years) underwent TDE. Final pathology showed adenoma in all patients including 1 (5{\%}) with invasive cancer, 2 (9{\%}) with microinvasive cancer, 6 (28{\%}) with high-grade dysplasia, and 1 (5{\%}) with low-grade dysplasia. The overall survival was 85{\%} (mean follow-up of 38 months). One of 3 late deaths was likely related to disease progression. Sixteen of the 18 remaining patients (89{\%}) had no evidence of tumor recurrence. One benign ampullary recurrence was successfully treated endoscopically. One additional patient developed an ampullary cancer and underwent pancreatoduodenectomy. Conclusions. TDE of benign ampullary tumors, even those with varying grades of dysplasia, can be performed with acceptable morbidity and low rates of recurrence. Postoperative endoscopic surveillance is mandatory to identify recurrent tumors.",
author = "Steven Posner and Lisa Colletti and James Knol and Michael Mulholland and Frederic Eckhauser",
year = "2000",
doi = "10.1067/msy.2000.108218",
language = "English (US)",
volume = "128",
pages = "694--701",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of vater

AU - Posner, Steven

AU - Colletti, Lisa

AU - Knol, James

AU - Mulholland, Michael

AU - Eckhauser, Frederic

PY - 2000

Y1 - 2000

N2 - Background. Ampullary tumors should be resected because of the high incidence of malignancy and the unreliability of preoperative endoscopic diagnosis. Controversy exists about whether to perform a transduodenal excision (TDE) or a pancreatoduodenectomy. This study evaluated the safety and long-term efficacy of TDE. Methods. The records of 21 patients with a pathologic diagnosis of ampullary adenoma who underwent TDE were reviewed. Demographics, symptoms, pathologic findings, and outcomes were analyzed and long-term follow-up was ascertained. Results. Twenty-one patients (mean age, 61 years) underwent TDE. Final pathology showed adenoma in all patients including 1 (5%) with invasive cancer, 2 (9%) with microinvasive cancer, 6 (28%) with high-grade dysplasia, and 1 (5%) with low-grade dysplasia. The overall survival was 85% (mean follow-up of 38 months). One of 3 late deaths was likely related to disease progression. Sixteen of the 18 remaining patients (89%) had no evidence of tumor recurrence. One benign ampullary recurrence was successfully treated endoscopically. One additional patient developed an ampullary cancer and underwent pancreatoduodenectomy. Conclusions. TDE of benign ampullary tumors, even those with varying grades of dysplasia, can be performed with acceptable morbidity and low rates of recurrence. Postoperative endoscopic surveillance is mandatory to identify recurrent tumors.

AB - Background. Ampullary tumors should be resected because of the high incidence of malignancy and the unreliability of preoperative endoscopic diagnosis. Controversy exists about whether to perform a transduodenal excision (TDE) or a pancreatoduodenectomy. This study evaluated the safety and long-term efficacy of TDE. Methods. The records of 21 patients with a pathologic diagnosis of ampullary adenoma who underwent TDE were reviewed. Demographics, symptoms, pathologic findings, and outcomes were analyzed and long-term follow-up was ascertained. Results. Twenty-one patients (mean age, 61 years) underwent TDE. Final pathology showed adenoma in all patients including 1 (5%) with invasive cancer, 2 (9%) with microinvasive cancer, 6 (28%) with high-grade dysplasia, and 1 (5%) with low-grade dysplasia. The overall survival was 85% (mean follow-up of 38 months). One of 3 late deaths was likely related to disease progression. Sixteen of the 18 remaining patients (89%) had no evidence of tumor recurrence. One benign ampullary recurrence was successfully treated endoscopically. One additional patient developed an ampullary cancer and underwent pancreatoduodenectomy. Conclusions. TDE of benign ampullary tumors, even those with varying grades of dysplasia, can be performed with acceptable morbidity and low rates of recurrence. Postoperative endoscopic surveillance is mandatory to identify recurrent tumors.

UR - http://www.scopus.com/inward/record.url?scp=0033780192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033780192&partnerID=8YFLogxK

U2 - 10.1067/msy.2000.108218

DO - 10.1067/msy.2000.108218

M3 - Article

VL - 128

SP - 694

EP - 701

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 4

ER -